Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,848,318
+$411,393 QoQ
Shares Held
29,948
+4.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.58%
of 13F equity value
Holder Rank
#1,173
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Shoker Investment Counsel, Inc. holds $20,628,640 across 8 Drug Manufacturers - General names. MRK ranks #3 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
21,930 | $5,518,465 | |
| 2 | JNJ |
Johnson & Johnson
|
18,845 | $4,786,064 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
29,948 | $3,848,318 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
20,774 | $2,624,587 | |
| 5 | PFE |
Pfizer Inc
|
99,923 | $2,406,145 | |
| 6 | LLY |
ELI LILLY & Co
|
668 | $801,219 | |
| 7 | NVS |
Novartis AG
|
2,335 | $365,941 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,823 | $277,901 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,848,318 | 29,948 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,436,925 | 28,572 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,100,854 | 29,459 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,431,284 | 28,968 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,270,546 | 28,683 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,490,929 | 27,751 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,689,441 | 27,035 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,028,758 | 26,671 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,400,786 | 27,470 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $3,787,492 | 28,704 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $3,123,641 | 28,652 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,908,543 | 28,252 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,301,307 | 28,610 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $3,065,840 | 28,817 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,229,754 | 29,110 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,471,902 | 28,703 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,504,075 | 27,466 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,160,376 | 26,330 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,004,749 | 26,158 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,968,407 | 26,207 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $1,945,805 | 25,020 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,892,329 | 24,547 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,017,677 | 24,666 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,027,050 | 24,437 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,881,130 | 24,326 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,852,637 | 24,079 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||